DR 5001

Drug Profile

DR 5001

Alternative Names: Adenovirus vaccine - Barr Laboratories; DR-5001

Latest Information Update: 14 Jun 2010

Price : $50

At a glance

  • Originator Barr Laboratories
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Adenovirus infections

Most Recent Events

  • 11 Dec 2008 Preregistration for Adenovirus infections in USA (PO)
  • 19 May 2008 Phase III development is ongoing
  • 30 Sep 2006 Phase-III clinical trials in Adenovirus infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top